Cholesterol Ester Storage Disease (CESD)
3 clinical trials · Condition
◉ Watch Cholesterol Ester Storage Disease (CESD)
| Record | Firm | Date |
|---|---|---|
| Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of SBC-102 (Sebelipase Alfa) in Adult Subjects With Lysosomal Acid Lipase Deficiency (NCT01488097) | Alexion Pharmaceuticals, Inc. | 2011-12-12 |
| An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype (NCT01528917) | Alexion Pharmaceuticals, Inc. | 2011-06-01 |
| Safety, Tolerability and Pharmacokinetics of SBC-102 (Sebelipase Alfa) in Adult Participants With Lysosomal Acid Lipase Deficiency (NCT01307098) | Alexion Pharmaceuticals, Inc. | 2011-04-25 |
Track Cholesterol Ester Storage Disease (CESD) automatically
Every clearance here is in the API, with alerts when new ones post.